ストックスクリーナーアプリを入手
19.98
3.43%
-0.71
前日終値:
$20.69
開ける：
$20.73
24時間の取引高:
81,851
Relative Volume:
0.75
時価総額：
$267.39M
収益：
$116.26M
当期純損益:
$-11.08M
株価収益率:
-25.24
EPS:
-0.7917
ネットキャッシュフロー:
$1.04M
1週間 パフォーマンス:
+2.04%
1か月 パフォーマンス:
-4.13%
6か月 パフォーマンス:
+29.82%
1年 パフォーマンス:
+119.80%
1日の値動き範囲:
$19.84
$20.75
1週間の範囲:
$19.32
$20.91
52週間の値動き範囲:
$8.6716
$22.88
Anika Therapeutics Inc Stock (ANIK) Company Profile
名前
Anika Therapeutics Inc
セクター
電話
(781) 457-9000
住所
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
19.98 | 267.39M | 116.26M | -11.08M | 1.04M | -0.7917 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-09-18 | 再開されました | B. Riley Securities | Buy |
| 2025-04-17 | 開始されました | B. Riley Securities | Buy |
| 2024-11-01 | 繰り返されました | Barrington Research | Outperform |
| 2023-08-14 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | 再開されました | Stephens | Equal-Weight |
| 2022-03-09 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | 開始されました | Stephens | Overweight |
| 2021-07-16 | 開始されました | UBS | Neutral |
| 2020-12-16 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | アップグレード | Sidoti | Neutral → Buy |
| 2020-01-10 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | 開始されました | BWS Financial | Sell |
| 2019-09-24 | 繰り返されました | Barrington Research | Outperform |
| 2019-09-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | ダウングレード | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2018-07-27 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | 繰り返されました | Barrington Research | Outperform |
| 2016-05-09 | アップグレード | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Anika Therapeutics Inc (ANIK) 最新ニュース
(ANIK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Anika Therapeutics Inc (ANIK) Shares Fall 3.5% -- GF Value Says Still Overvalued - GuruFocus
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Anika Therapeutics, Inc. (ANIK) Stock Price, News, Quote & History - Yahoo! Finance Canada
B.Riley assumes Anika Therapeutics stock coverage with buy rating - Investing.com
B. Riley Securities Initiates Anika Therapeutics(ANIK.US) With Buy Rating, Announces Target Price $23 - Moomoo
FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug - TradingView
Technical Reactions to ANIK Trends in Macro Strategies - news.stocktradersdaily.com
Anika Therapeutics (ANIK) Retreats 1.06% as Shares Hold Above Key $19.56 SupportWave Extension - siam.in
Anika Therapeutics Inc. (ANIK) News, Articles, Events & Latest Updates - Stocktwits
Best Momentum Stocks to Buy for August 26th - Yahoo Finance
Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why? - TradingView
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why? - Yahoo Finance
Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know - Yahoo Finance
Anika Therapeutics, Inc. (ANIK) stock price, news, quote and history - Yahoo Finance Singapore
Zacks.com featured highlights include OptimumBank, EuroDry, Enova International, Anika Therapeutics and The GEO - Yahoo Finance
Understanding Momentum Shifts in (ANIK) - Stock Traders Daily
Anika Therapeutics Stock Price Forecast. Should You Buy ANIK? - StockInvest.us
Anika Therapeutics, Inc. (ANIK) stock price, news, quote and history - Yahoo Finance UK
ANIK (NASDAQ: ANIK) holder plans Form 144 sale of 16,864 shares - stocktitan.net
Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Anika Therapeutics (NASDAQ:ANIK) Raised to Strong-Buy at Zacks Research - MarketBeat
Anika Therapeutics (ANIK) Insider Gary Fischetti Buys 2,000 Shar - GuruFocus
Anika Therapeutics Inc (ANIK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anika Therapeutics (NASDAQ:ANIK) Director Purchases 1,000 Shares - MarketBeat
Anika Therapeutics (ANIK) director purchases 2,000 common shares in market buys - Stock Titan
Anika Therapeutics (ANIK) Dips 2.14% to $19.19 as Support Level Comes into FocusStock Surge Alerts - vinanet.vn
Anika Therapeutics (ANIK) Dips 2.14% to $19.19 as Support Level Comes into FocusModified Schiff - careplusvn.com
Anika Therapeutics Lifts Outlook After Margin Surge - TipRanks
Q1 2025 Anika Therapeutics Inc Earnings Call Transcript - GuruFocus
Anika Therapeutics Lifts Outlook After Margin Surge - The Globe and Mail
Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance - Yahoo Finance
Anika Therapeutics Gains 29%, Insider Trades Reap Benefit - Moomoo
Wall Street Zen Upgrades Anika Therapeutics (NASDAQ:ANIK) to Strong-Buy - MarketBeat
Anika Therapeutics Inc. Revenue Breakdown – NASDAQ:ANIK - TradingView
Anika Therapeutics expands Integrity implant reach with 3,300 U.S. procedures and international availability - Traders Union
Vanguard Capital Management (ANIK) discloses 4.95% beneficial stake in Anika Therapeutics - Stock Titan
B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating - Moomoo
B. Riley Securities Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Raises Target Price to $21 - Moomoo
Anika Therapeutics (ANIK) Surges 7.8%: Technical Breakout in MotionPut Flow Alert - vinanet.vn
Anika Therapeutics Q2 2026 slides: margins surge, guidance raised By Investing.com - Investing.com Nigeria
Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: - GuruFocus
Is Anika Therapeutics Inc (ANIK) On The Rise After Q2 Earnings B - GuruFocus
Anika Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Transcript : Anika Therapeutics, Inc., Q2 2026 Earnings Call, Jul 29, 2026 - marketscreener.com
Anika Therapeutics Q2 revenue rises 16% to $32.6 million - Quiver Quantitative
Anika: Q2 Earnings Snapshot - KING5.com
BRIEF-Anika Therapeutics Q2 Revenue USD 32.61 Million - TradingView
Anika Therapeutics Inc (ANIK) 財務データ
収益
当期純利益
現金流量
EPS
Anika Therapeutics Inc (ANIK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Fischetti Gary P | Director |
Aug 04 '26 |
Buy |
20.32 |
1,000 |
20,315 |
54,015 |
| Fischetti Gary P | Director |
Aug 03 '26 |
Buy |
20.75 |
1,000 |
20,745 |
53,015 |
| HENNEMAN JOHN B III | Director |
May 01 '26 |
Buy |
14.66 |
5,000 |
73,320 |
54,871 |
| Griffin Stephen D. | President and CEO |
Apr 30 '26 |
Buy |
12.29 |
12,200 |
149,881 |
36,163 |
2.68%
大文字化:
|
ボリューム (24 時間):